We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
US-based chipmaker Nvidia has entered into a partnership with GlaxoSmithKline (GSK) and its artificial intelligence (AI) group for the discovery of drugs and vaccines.
The Scripps Research Translational Institute is partnering with graphics firm NVIDIA to develop AI and deep learning best practices, tools and infrastructure to develop AI applications using genomic and digital health sensor data